Key facts
- Notable investors include Service Provider Capital, Pimlico Pond Investments, Govo Venture Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Medzown
- ·The full record, as it builds
Funding rounds
No funding rounds for Medzown are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Medzown
Developer of a precision medicine management platform designed to bridge the gap between patients and treatments. The company uses advanced analytics and expertise to provide patients and their care teams with strategies to evaluate treatment options and clinical trials, enabling healthcare professionals to provide better care, achieve better patient outcomes, and increase efficiency while reducing administrative costs.
- Sector
- Healthcare
- HQ
- Jupiter, FL, United States
- Founded
- 2022
- Employees
- 37
- Website
- medzown.com/
- Ownership
- Privately Held (backing)
Medzown doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medzown shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medzown in its N-PORT filings yet. We sweep new filings monthly.